Focus on renal congestion in heart failure

Clinical Kidney Journal
Baris AfsarMehmet Kanbay

Abstract

Hospitalizations due to heart failure are increasing steadily despite advances in medicine. Patients hospitalized for worsening heart failure have high mortality in hospital and within the months following discharge. Kidney dysfunction is associated with adverse outcomes in heart failure patients. Recent evidence suggests that both deterioration in kidney function and renal congestion are important prognostic factors in heart failure. Kidney congestion in heart failure results from low cardiac output (forward failure), tubuloglomerular feedback, increased intra-abdominal pressure or increased venous pressure. Regardless of the cause, renal congestion is associated with increased morbidity and mortality in heart failure. The impact on outcomes of renal decongestion strategies that do not compromise renal function should be explored in heart failure. These studies require novel diagnostic markers that identify early renal damage and renal congestion and allow monitoring of treatment responses in order to avoid severe worsening of renal function. In addition, there is an unmet need regarding evidence-based therapeutic management of renal congestion and worsening renal function. In the present review, we summarize the mechanisms, d...Continue Reading

References

Nov 1, 1982·Annals of Surgery·P K HarmanS P Nolan
Jun 1, 1997·The Journal of Trauma·G L BloomfieldH J Sugerman
Aug 16, 2001·Critical Care Medicine·J A Kellum, J M Decker
Nov 11, 2003·European Journal of Heart Failure·Thomas PeschelJosef Niebauer
Dec 22, 2004·Circulation·Paolo C ColomboThierry H LeJemtel
Apr 21, 2005·JAMA : the Journal of the American Medical Association·Jonathan D Sackner-BernsteinKeith Aaronson
Jan 3, 2006·Journal of the American College of Cardiology·Robert W Schrier
Apr 6, 2006·Journal of Internal Medicine·D G HarrisonC Searles
Jul 25, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Simone GonçalvesMiguel C Riella
Nov 16, 2006·The New England Journal of Medicine·Robert W SchrierUNKNOWN SALT Investigators
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
Aug 28, 2007·European Journal of Heart Failure·Vic HasselbladKirkwood F Adams
Apr 1, 1949·The American Journal of Physiology·W D BLAKE, R WEGRIA
Sep 2, 2008·Heart Failure Clinics·Ron Blankstein, George L Bakris
Sep 2, 2008·European Journal of Heart Failure·Alan MaiselEugene Braunwald
Feb 14, 2009·Journal of the American College of Cardiology·Wilfried MullensW H Wilson Tang
Jun 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Shuchong PanRobert D Simari
Sep 29, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jose E SánchezFrancisco Ortega
Mar 11, 2010·Internal Medicine Journal·R PfisterC A Schneider
Apr 29, 2010·Current Heart Failure Reports·Anjali GandaPaolo C Colombo
Jun 16, 2010·Circulation·Jeremy S Bock, Stephen S Gottlieb
Aug 7, 2010·Congestive Heart Failure·G Michael Felker
Aug 19, 2010·International Heart Journal·Hiroki ShiomiKeizo Furukawa
Oct 12, 2010·The New England Journal of Medicine·Barry M MassieUNKNOWN PROTECT Investigators and Committees
Mar 4, 2011·The New England Journal of Medicine·G Michael FelkerUNKNOWN NHLBI Heart Failure Clinical Research Network
Mar 12, 2011·American Heart Journal·Enrico FiaccadoriAderville Cabassi
Jul 8, 2011·The New England Journal of Medicine·C M O'ConnorR M Califf
Jul 26, 2011·European Heart Journal·Piero Ruggenenti, Giuseppe Remuzzi

❮ Previous
Next ❯

Citations

Aug 31, 2016·Nature Reviews. Nephrology·Joerg C SchefoldStephan von Haehling
Oct 21, 2017·Clinical and Experimental Nephrology·Satoshi MinamiYoshitaka Isaka
Jul 13, 2018·Drug Discoveries & Therapeutics·Yohei OnoMasahiko Kurabayashi
Aug 7, 2018·Congenital Heart Disease·Christopher R BrodaJack F Price
Jul 18, 2019·Current Opinion in Pulmonary Medicine·Joanne A GroeneveldtBerend E Westerhof
Jan 11, 2020·Journal of the American Society of Nephrology : JASN·Junichi IshigamiKunihiro Matsushita
Sep 2, 2020·Journal of Nephrology·Giacomo DeferrariEdoardo La Porta
Oct 6, 2018·Clinical Medicine : Journal of the Royal College of Physicians of London·Mike Jones, Charles Tomson
Aug 1, 2019·Current Opinion in Pulmonary Medicine·Joanne A GroeneveldtBerend E Westerhof
May 13, 2017·Heart Failure Reviews·Baris AfsarMehmet Kanbay
Oct 11, 2020·CEN Case Reports·Tomoki TaniguchiKenichiro Takashina
Oct 13, 2020·Cardiac Failure Review·Ingibjörg KristjánsdóttirLars H Lund
Sep 8, 2020·Critical Care Clinics·Mira KüllmarNana-Maria Wagner
Feb 8, 2021·British Journal of Anaesthesia·Marcos G LopezFrederic T Billings
Nov 20, 2020·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Adrian CovicMehmet Kanbay
May 21, 2021·Medical Devices : Evidence and Research·Emanuela MarcelliGianni Plicchi
Sep 18, 2021·Journal of the American Heart Association·Miriam T RademakerA Mark Richards
Sep 28, 2021·Frontiers in Medicine·Babak YazdaniMarcus E Kleber

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01896908
NCT01474200

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.